We would like to welcome Dr Akila Viswanathan to the Johns Hopkins Kimmel Cancer Center's podcast network. In her debut, she speaks with Dr Jeffrey… Read More »On Target with Dr. Akila Viswanathan – Gastrointestinal Cancers
The FDA has approved a new drug treatment for a type of brain cancer called low-grade glioma. The drug, called vorasidenib, is a targeted cancer… Read More »FDA Approves Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
In the next Cancer Matters podcast, Dr Bill Nelson speaks with Dr B Douglas Smith about treating leukemia patients with targeted therapies that reduce toxicities… Read More »Cancer Matters with Dr. Bill Nelson – Targeting Leukemia
Pictured: Nanoparticles releasing microRNAs inside a brain cancer cell. Johns Hopkins Kimmel Cancer Center brain cancer researchers announced that they successfully delivered ultra-tiny nano-size packets… Read More »Special Delivery Targets Brain Cancer Cells
Last week's news announcement of a new drug target for asthma and cancer heralded an example of the type of out-of-the-box thinking that has now… Read More »Out-of-the-box science finds drug target for cancer and asthma
Valerie is the senior science writer and publications editor for the Kimmel Cancer Center. She has been a member of the public affairs team for… Read More »Valerie Matthews Mehl
In this Cancer Matters podcast, Dr Bill Nelson talks to Terri Conneran, the founder of KRAS Kickers, about the discovery of biomarkers, targeted treatments and… Read More »Cancer Matters with Dr. Bill Nelson – KRAS Kickers
New faculty member Joseph Murray, M.D., Ph.D., believes data holds the answers to many unsolved mysteries about esophageal cancer. Symptoms, imaging, outcomes, treatments received, and… Read More »It’s in the Data
Liver cancer is one of the fastest-growing causes of cancer death in the U.S. and in many other parts of the world, says Mark Yarchoan,… Read More »Combatting Liver Cancer
Arnold’s advanced pancreas cancer that had spread to his liver was eliminated with a low-dose, five-drug combination being studied in a clinical trial led by… Read More »New Advances in Therapies: Five-Drug Combo